GNIIF (GNI Group) Quality Rank


GNIIF GNI Group Ltd GNIIF
86 GF Score
Price $15.50
GF Value $16.57
! 5 Warning Signs
View Full Analysis

What is GNI Group Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

GNI Group Quality Rank Related Terms

GNIIF
86GF Score
GNI Group Ltd GNIIF
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GNI Group (GNIIF) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of $15.50 is trading 6.5% below its estimated GF Value™ of $16.57.

Key valuation signals for GNIIF:

  • Quality Rank:
  • GF Value™: $16.57 vs. price of $15.50 (6.5% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the GNIIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GNI Group Business Description

Other Exchanges 2160:Japan
Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
86GF Score

Get the complete analysis for GNIIF

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.50
Price
$16.57
GF Value